These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 12664816)

  • 1. Transcatheter closure of patent foramen ovale: a new migraine treatment?
    Morandi E; Anzola GP; Angeli S; Melzi G; Onorato E
    J Interv Cardiol; 2003 Feb; 16(1):39-42. PubMed ID: 12664816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does transcatheter closure of patent foramen ovale really "shut the door?" A prospective study with transcranial Doppler.
    Anzola GP; Morandi E; Casilli F; Onorato E
    Stroke; 2004 Sep; 35(9):2140-4. PubMed ID: 15284445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.
    Manolis AS
    Rev Recent Clin Trials; 2017; 12(2):129-138. PubMed ID: 28356032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of patent foramen ovale diagnosis with transcranial Doppler.
    Anzola GP
    Eur J Ultrasound; 2002 Nov; 16(1-2):11-20. PubMed ID: 12470846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of migraine headache relief following patent foramen ovale "closure" despite residual right-to-left shunt.
    Jesurum JT; Fuller CJ; Kim CJ; Krabill KA; Spencer MP; Olsen JV; Likosky WH; Reisman M
    Am J Cardiol; 2008 Oct; 102(7):916-20. PubMed ID: 18805122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Residual Interatrial Shunt on Migraine Burden After Transcatheter Closure of Patent Foramen Ovale.
    Ben-Assa E; Rengifo-Moreno P; Al-Bawardy R; Kolte D; Cigarroa R; Cruz-Gonzalez I; Sakhuja R; Elmariah S; Pomerantsev E; Vaina LM; Ning M; Buonanno FS; Hung JW; Inglessis I; Palacios IF
    JACC Cardiovasc Interv; 2020 Feb; 13(3):293-302. PubMed ID: 32029246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ICE-guided patent foramen ovale (PFO) closure with lastest-generation devices: the ideal strategy for PFO-related migraine?
    Rigatelli G; Cardaioli P; Braggion G; Giordan M; Aggio S; Roncon L
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):633-5. PubMed ID: 17667037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of migraine by transcatheter patent foramen ovale closure with Premere Occlusion System in a preliminary series of patients with previous cerebral ischemia.
    Rigatelli G; Cardaioli P; Braggion G; Giordan M; Fabio D; Aggio S; Roncon L; Chinaglia M
    Catheter Cardiovasc Interv; 2007 Sep; 70(3):429-33. PubMed ID: 17722021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM Trial.
    Tobis JM; Charles A; Silberstein SD; Sorensen S; Maini B; Horwitz PA; Gurley JC
    J Am Coll Cardiol; 2017 Dec; 70(22):2766-2774. PubMed ID: 29191325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of migraine headaches after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism.
    Wahl A; Praz F; Tai T; Findling O; Walpoth N; Nedeltchev K; Schwerzmann M; Windecker S; Mattle HP; Meier B
    Heart; 2010 Jun; 96(12):967-73. PubMed ID: 20538672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Migraine headache relief after transcatheter closure of patent foramen ovale.
    Reisman M; Christofferson RD; Jesurum J; Olsen JV; Spencer MP; Krabill KA; Diehl L; Aurora S; Gray WA
    J Am Coll Cardiol; 2005 Feb; 45(4):493-5. PubMed ID: 15708692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shunt-associated migraine responds favorably to atrial septal repair: a case-control study.
    Anzola GP; Frisoni GB; Morandi E; Casilli F; Onorato E
    Stroke; 2006 Feb; 37(2):430-4. PubMed ID: 16373630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy of transcatheter patent foramen ovale closure on migraine headache with aura and recurrent stroke.
    Giardini A; Donti A; Formigari R; Salomone L; Palareti G; Guidetti D; Picchio FM
    Catheter Cardiovasc Interv; 2006 Apr; 67(4):625-9. PubMed ID: 16548006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism.
    Rigatelli G; Dell'Avvocata F; Ronco F; Cardaioli P; Giordan M; Braggion G; Aggio S; Chinaglia M; Rigatelli G; Chen JP
    JACC Cardiovasc Interv; 2010 Mar; 3(3):282-7. PubMed ID: 20298985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter patent foramen ovale closure is effective in reducing migraine independently from specific interatrial septum anatomy and closure devices design.
    Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Braggion G; Chinaglia M; Roncon L
    Cardiovasc Revasc Med; 2010; 11(1):29-33. PubMed ID: 20129358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of transcatheter patent foramen ovale closure in patients with paradoxical embolism.
    Cifarelli A; Musto C; Parma A; Pandolfi C; Pucci E; Fiorilli R; De Felice F; Nazzaro MS; Violini R
    Int J Cardiol; 2010 Jun; 141(3):304-10. PubMed ID: 19178959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting.
    Giardini A; Donti A; Formigari R; Salomone L; Prandstraller D; Bonvicini M; Palareti G; Guidetti D; Gaddi O; Picchio FM
    Am Heart J; 2006 Apr; 151(4):922.e1-5. PubMed ID: 16569564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Closure of a patent foramen ovale: effective therapy of migraine and occipital stroke.
    Finsterer J; Sommer O; Stiskal M; Stöllberger C; Baumgartner H
    Int J Neurosci; 2005 Jan; 115(1):119-27. PubMed ID: 15768856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
    Chatterjee T; Petzsch M; Ince H; Rehders TC; Körber T; Weber F; Schneider H; Auf der Maur C; Nienaber CA
    J Interv Cardiol; 2005 Jun; 18(3):173-9. PubMed ID: 15966921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medium-term results of transcatheter closure of patent foramen ovale (PFO) with Amplatzer PFO and Cribriform occluders.
    Białkowski J; Wawrzyńczyk M; Karwot B; Fiszer R; Knop M; Szkutnik M
    Kardiol Pol; 2012; 70(11):1142-6. PubMed ID: 23180522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.